Prolonged loss of consciousness and elevated porphyrins following propofol administrations.
Asirvatham
S J
SJ
Department of Cardiology, University of Oklahoma Health Sciences Center, Oklahoma City, USA. Asirvatham.samuel@mayo.edu
Johnson
T W
TW
Oberoi
M P
MP
Jackman
W M
WM
D000328:Adult; D000622:Aminolevulinic Acid / Q000652:urine; D018686:Anesthetics, Intravenous / Q000009:adverse effects*; D003306:Coproporphyrins / Q000652:urine; D006801:Humans; D008297:Male; D011162:Porphobilinogen / Q000652:urine; D011166:Porphyrins / Q000652:urine*; D015742:Propofol / Q000009:adverse effects*; D014474:Unconsciousness / Q000139:chemically induced* / Q000652:urine*
D018686:Anesthetics, Intravenous; D003306:Coproporphyrins; D011166:Porphyrins; C026971:coproporphyrin III; D011162:Porphobilinogen; D000622:Aminolevulinic Acid; D015742:Propofol